Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005213

Vice Pres Sales & Marketing gave up 593 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bitterman Chris T. Vice Pres Sales & Marketing 2024-03-23 Shares withheld for taxes −593 $1.81 $1,073 4,683 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bitterman Chris T. Vice Pres Sales & Marketing 2024-03-25 Grant or award · Options (right to buy) +2,750 $1.71 $4,703 13,250 D: show line 2 in the form
Loading xslF345X05/marketforms-65387.xml…